6 studies found for:    elnd005
Show Display Options
Rank Status Study
1 Enrolling by invitation A 12-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Group 1 ELND005;   Drug: Group 2 ELND005
2 Recruiting A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Condition: Down Syndrome
Interventions: Drug: ELND005;   Drug: Placebo
3 Completed ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: ELND005 (scyllo-inositol)
4 Completed
Has Results
ELND005 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Placebo Control;   Drug: ELND005
5 Recruiting Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ELND005;   Drug: Placebo
6 Active, not recruiting Safety and Efficacy Study of ELND005 as an Adjunctive Maintenance Treatment in Bipolar I Disorder
Condition: Bipolar 1 Disorder
Interventions: Drug: ELND005;   Drug: Lamotrigine;   Drug: Valproic acid;   Drug: Placebo

Indicates status has not been verified in more than two years